From the Chief Executive
Bill Gates’ recent visit to Australia attracted a lot of attention, and rightly so. His contribution, and that of the Bill and Malinda Gates Foundation, to global health and reducing poverty is legendary.
The world’s richest man and global philanthropist attracted many tributes from Australians while here for his free-speaking, honesty and obvious compassion.
In his address to the National Press Club, Gates spent some time explaining the contribution of the medicines industry, and the medicines and vaccines it makes, to his global effort to improve health…
News and Updates
Medicines industry applauds R&D regulatory reform - 18 June
Medicines Australia today welcomed the Coalition’s announcements that it will reduce red tape, protect medical research funding and provide policy certainty in medical research.
“Regulatory reform is an important part of encouraging medical R&D and the Coalition’s recent announcements on this are welcome,” said Dr Brendan Shaw, Chief Executive.
Medicines Australia CEO to sleep out for homeless - 31 May
Medicines Australia chief executive Dr Brendan Shaw will again brave the depths of Canberra’s winter this year, sleeping rough in a cardboard box to raise money in support of homeless Australians.
Dr Shaw will be participating in the St Vincent de Paul CEO Sleepout on 20 June, in Civic Square in Canberra. The Sleepout is conducted at centres around Australia.
“It’s a great thing to do for a good cause,” Dr Shaw said.
New Government must fix PBS listing system - 27 May
Medicines Australia today launched its 2013 Federal Election document, calling on all sides of politics to fix deficiencies in the Pharmaceutical Benefits Scheme and restore confidence in the process that makes new medicines available to patients.
Launching Medicines Now: the 2013 Federal Election, Medicines Australia chief executive Dr Brendan Shaw said patients were already missing out on some new medicines because the PBS listing system had become too difficult.
Number of new PBS medicines hits 20-year low - 20 May
The number of new medicines listed on the Pharmaceutical Benefits Scheme in 2011-12 was the lowest for 20 years, according to a ground-breaking report released today by the Centre for Strategic Economic Studies.
The Impact of Further PBS Reforms study also found that reforms to the PBS agreed between the Commonwealth and Medicines Australia over the last decade will deliver up to $18 billion in savings.
Spotlight
